These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 7481417

  • 1. Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination.
    Bjorvatn B, Bjørkum AA, Neckelmann D, Ursin R.
    Sleep; 1995 Jul; 18(6):451-62. PubMed ID: 7481417
    [Abstract] [Full Text] [Related]

  • 2. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
    Bjorvatn B, Ursin R.
    Behav Brain Res; 1990 Nov 30; 40(3):239-46. PubMed ID: 2149499
    [Abstract] [Full Text] [Related]

  • 3. Sleep-wake and eeg effects following adenosine a1 agonism and antagonism: similarities and interactions with sleep-wake and eeg effects following a serotonin reuptake inhibitor in rats.
    Ursin R, Bjorvatn B.
    Sleep Res Online; 1998 Nov 30; 1(3):119-27. PubMed ID: 11382868
    [Abstract] [Full Text] [Related]

  • 4. Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in cats.
    Sommerfelt L, Ursin R.
    Behav Brain Res; 1991 Nov 26; 45(2):105-15. PubMed ID: 1838688
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The 5-HT1A antagonist (-)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in rats.
    Bjorvatn B, Neckelmann D, Ursin R.
    Pharmacol Biochem Behav; 1992 May 26; 42(1):49-56. PubMed ID: 1388278
    [Abstract] [Full Text] [Related]

  • 7. Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopram.
    Neckelmann D, Bjørkum AA, Bjorvatn B, Ursin R.
    Behav Brain Res; 1996 Feb 26; 75(1-2):159-68. PubMed ID: 8800653
    [Abstract] [Full Text] [Related]

  • 8. Sleep/waking effects following intrathecal administration of the 5-HT(1A) Agonist 8-OH-DPAT alone and in combination with the putative 5-HT(1A) antagonist NAN-190 in rats.
    Bjørkum AA, Ursin R.
    Brain Res Bull; 1996 Feb 26; 39(6):373-9. PubMed ID: 9138747
    [Abstract] [Full Text] [Related]

  • 9. The effects of zimeldine and alaproclate combined with a small dose of 5-HTP on waking and sleep stages in cats.
    Sommerfelt L, Ursin R.
    Behav Brain Res; 1987 Apr 26; 24(1):1-10. PubMed ID: 2953350
    [Abstract] [Full Text] [Related]

  • 10. Lesion of descending 5-HT pathways increases zimeldine-induced waking in rats.
    Bjørkum AA, Neckelmann D, Bjorvatn B, Ursin R.
    Physiol Behav; 1995 May 26; 57(5):959-66. PubMed ID: 7610150
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The 5-HT2 antagonist ritanserin decreases sleep in cats.
    Sommerfelt L, Ursin R.
    Sleep; 1993 Jan 26; 16(1):15-22. PubMed ID: 8456229
    [Abstract] [Full Text] [Related]

  • 14. Diurnal differences in L-tryptophan sleep and temperature effects in the rat.
    Olsen OE, Neckelmann D, Ursin R.
    Behav Brain Res; 1994 Dec 15; 65(2):195-203. PubMed ID: 7718152
    [Abstract] [Full Text] [Related]

  • 15. Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administration.
    Neckelmann D, Bjorvatn B, Bjørkum AA, Ursin R.
    Behav Brain Res; 1996 Sep 15; 79(1-2):183-92. PubMed ID: 8883829
    [Abstract] [Full Text] [Related]

  • 16. Chronic zimeldine administration to cats: sustained increase of serotonergic effect as measured with sleep parameters.
    Sommerfelt L.
    Pharmacol Toxicol; 1990 Feb 15; 66(2):128-32. PubMed ID: 2138291
    [Abstract] [Full Text] [Related]

  • 17. Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity.
    Kostyalik D, Kátai Z, Vas S, Pap D, Petschner P, Molnár E, Gyertyán I, Kalmár L, Tóthfalusi L, Bagdy G.
    Exp Brain Res; 2014 Mar 15; 232(3):935-46. PubMed ID: 24395141
    [Abstract] [Full Text] [Related]

  • 18. Sleep-wake effects following the selective 5-HT(1A) receptor antagonist p-MPPI in the freely moving rat.
    Sørensen E, Bjorvatn B, Ursin R.
    Behav Brain Res; 2000 Sep 15; 114(1-2):31-8. PubMed ID: 10996044
    [Abstract] [Full Text] [Related]

  • 19. A selective serotonin reuptake inhibitor reduces REM sleep in the homing pigeon.
    Fuchs T, Siegel JJ, Burgdorf J, Bingman VP.
    Physiol Behav; 2006 Mar 30; 87(3):575-81. PubMed ID: 16469340
    [Abstract] [Full Text] [Related]

  • 20. Serotonergic control of ingestive and post-ingestive behaviors in pigeons (Columba livia): the role of 5-HT1A receptor-mediated central mechanisms.
    Hoeller AA, Dos Santos TS, Bruxel RR, Dallazen AR, do Amaral Silva HT, André ES, Marino-Neto J.
    Behav Brain Res; 2013 Jan 01; 236(1):118-130. PubMed ID: 22954717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.